Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 8-K Event Regulation FD disclosure · Other events
  4. 8-K Event Other events
  5. 424B5 Offering Prospectus
  6. 424B3 Offering Prospectus
  7. 8-K Event Regulation FD disclosure · Other events
  8. 8-K Event Material agreement · Agreement ended · New debt or obligation
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. 8-K Event Auditor change
  14. 4 Grant or award Director acquired 30,000 shares (grant or award)
  15. 4 Grant or award Director acquired 30,000 shares (grant or award)
  16. 4 Grant or award Director acquired 30,000 shares (grant or award)
  17. 4 Grant or award Director acquired 30,000 shares (grant or award)
  18. 4 Grant or award Director acquired 30,000 shares (grant or award)
  19. 4 Grant or award Director acquired 30,000 shares (grant or award)
  20. 4 Grant or award Director acquired 30,000 shares (grant or award)

Page 1 of 47 · 923 filings